-
1
-
-
0037133126
-
Targeting to macrophages: Role of physicochemical properties of particulate carriers - Liposomes and microspheres - On the phagocytosis by macrophages
-
DOI 10.1016/S0168-3659(01)00549-1, PII S0168365901005491
-
Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release, 79, 29-40. (Pubitemid 34164159)
-
(2002)
Journal of Controlled Release
, vol.79
, Issue.1-3
, pp. 29-40
-
-
Ahsan, F.1
Rivas, I.P.2
Khan, M.A.3
Torres, S.A.I.4
-
2
-
-
77953159547
-
Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches
-
Akande J, Yeboah KG, Addo RT, Siddig A, Oettinger CW, D'Souza MJ. (2010). Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches. J Microencapsul, 27, 325-336.
-
(2010)
J Microencapsul
, vol.27
, pp. 325-336
-
-
Akande, J.1
Yeboah, K.G.2
Addo, R.T.3
Siddig, A.4
Oettinger, C.W.5
D'Souza, M.J.6
-
3
-
-
79955719446
-
Sipuleucel-T (provenge) injection: The first immunotherapy agent (vaccine) for hormone-refractory prostate cancer
-
Anassi E, Ndefo UA. (2011). Sipuleucel-T (provenge) injection: The first immunotherapy agent (vaccine) for hormone-refractory prostate cancer. P T, 36, 197-202.
-
(2011)
P T
, vol.36
, pp. 197-202
-
-
Anassi, E.1
Ndefo, U.A.2
-
4
-
-
79955821513
-
A novel microparticulate vaccine for melanoma cancer using transdermal delivery
-
Bhowmik T, D'Souza B, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza MJ. (2011). A novel microparticulate vaccine for melanoma cancer using transdermal delivery. J Microencapsul, 28, 294-300.
-
(2011)
J Microencapsul
, vol.28
, pp. 294-300
-
-
Bhowmik, T.1
D'Souza, B.2
Shashidharamurthy, R.3
Oettinger, C.4
Selvaraj, P.5
D'Souza, M.J.6
-
5
-
-
78650919399
-
Translating tumor antigens into cancer vaccines
-
Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM. (2011). Translating tumor antigens into cancer vaccines. Clin Vaccine Immunol, 18, 23-34.
-
(2011)
Clin Vaccine Immunol
, vol.18
, pp. 23-34
-
-
Buonaguro, L.1
Petrizzo, A.2
Tornesello, M.L.3
Buonaguro, F.M.4
-
6
-
-
84872374860
-
Human Serum Albumin as a Pharmaceutical Excipient
-
Chaubal M. (2005). Human Serum Albumin as a Pharmaceutical Excipient. Drug Dev Deliv, 5.
-
(2005)
Drug Dev Deliv
, pp. 5
-
-
Chaubal, M.1
-
7
-
-
75849124774
-
-
Available at: Accessed on 28 August 2011
-
Clinical trials. (2011). Available at: http://clinicaltrials.gov/ct2/ results?term=prostate+cancer+vaccine. Accessed on 28 August 2011.
-
(2011)
Clinical Trials
-
-
-
8
-
-
77953472155
-
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
-
Di Costanzo F, Gasperoni S, Rotella V, Di Costanzo F. (2009). Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer. Onco Targets Ther, 2, 179-188.
-
(2009)
Onco Targets Ther
, vol.2
, pp. 179-188
-
-
Di Costanzo, F.1
Gasperoni, S.2
Rotella, V.3
Di Costanzo, F.4
-
9
-
-
84855662860
-
Oral microparticulate vaccine for melanoma using M-cell targeting
-
D'Souza B, Bhowmik T, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza M. (2012). Oral microparticulate vaccine for melanoma using M-cell targeting. J Drug Target, 20, 166-173.
-
(2012)
J Drug Target
, vol.20
, pp. 166-173
-
-
D'Souza, B.1
Bhowmik, T.2
Shashidharamurthy, R.3
Oettinger, C.4
Selvaraj, P.5
D'Souza, M.6
-
10
-
-
0029637159
-
Site specific microencapsulated drug targeting strategies to the liver and the gastrointestinal tract
-
D'Souza MJ, DeSouza PJ. (1995). Site specific microencapsulated drug targeting strategies to the liver and the gastrointestinal tract. Adv Drug Deliv Rev, 17, 247-254.
-
(1995)
Adv Drug Deliv Rev
, vol.17
, pp. 247-254
-
-
D'Souza, M.J.1
DeSouza, P.J.2
-
11
-
-
0032941902
-
Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma
-
D'Souza M, Pourfarzib R. (1999). Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma. Drug Dev Ind Pharm, 25, 585-592.
-
(1999)
Drug Dev Ind Pharm
, vol.25
, pp. 585-592
-
-
D'Souza, M.1
Pourfarzib, R.2
-
12
-
-
4344697146
-
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
-
Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IF, Plebanski M. (2004). Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors. J Immunol, 173, 3148-3154. (Pubitemid 39142021)
-
(2004)
Journal of Immunology
, vol.173
, Issue.5
, pp. 3148-3154
-
-
Fifis, T.1
Gamvrellis, A.2
Crimeen-Irwin, B.3
Pietersz, G.A.4
Li, J.5
Mottram, P.L.6
McKenzie, I.F.C.7
Plebanski, M.8
-
13
-
-
21344448185
-
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
-
DOI 10.1016/j.ijpharm.2005.03.035, PII S0378517305002449, Selected Contribution from the 5th European Workshop on Particulate Systems
-
Foged C, Brodin B, Frokjaer S, Sundblad A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm, 298, 315-322. (Pubitemid 40910735)
-
(2005)
International Journal of Pharmaceutics
, vol.298
, Issue.2
, pp. 315-322
-
-
Foged, C.1
Brodin, B.2
Frokjaer, S.3
Sundblad, A.4
-
14
-
-
84859554375
-
-
Available at: Accessed on 28 August 2011
-
Garnick MB. (2010). Prostrate cancer: Screening, diagnosis, and management. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/ prostate/HealthProfessional/page1#Reference1.2. Accessed on 28 August 2011.
-
(2010)
Prostrate Cancer: Screening, Diagnosis, and Management
-
-
Garnick, M.B.1
-
15
-
-
70449558745
-
Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres
-
Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D'Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. J Microencapsul, 26, 692-700.
-
(2009)
J Microencapsul
, vol.26
, pp. 692-700
-
-
Gayakwad, S.G.1
Bejugam, N.K.2
Akhavein, N.3
Uddin, N.A.4
Oettinger, C.E.5
D'Souza, M.J.6
-
16
-
-
0034731393
-
Expression of specific markers and particle transport in a new human intestinal M-cell model
-
DOI 10.1006/bbrc.2000.4038
-
Gullberg E, Leonard M, Karlsson J, Hopkins AM, Brayden D, Baird AW, Artursson P. (2000). Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun, 279, 808-813. (Pubitemid 32042860)
-
(2000)
Biochemical and Biophysical Research Communications
, vol.279
, Issue.3
, pp. 808-813
-
-
Gullberg, E.1
Leonard, M.2
Karlsson, J.3
Hopkins, A.M.4
Brayden, D.5
Baird, A.W.6
Artursson, P.7
-
17
-
-
1842372075
-
Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
-
DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0
-
Jäger E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jäger D, Oesch F, Knuth A. (1997). Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer, 71, 142-147. (Pubitemid 27252981)
-
(1997)
International Journal of Cancer
, vol.71
, Issue.2
, pp. 142-147
-
-
Jager, E.1
Ringhoffer, M.2
Altmannsberger, M.3
Arand, M.4
Karbach, J.5
Jager, D.6
Oesch, F.7
Knuth, A.8
-
18
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, Ward E. (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
19
-
-
55349109633
-
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDGmicroPET or external caliper
-
doi: 10.1186/1471-2342-8-16
-
Jensen MM, Jørgensen JT, Binderup T, Kjaer A. (2008). Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDGmicroPET or external caliper. BMC Med Imaging, 8, 16. doi: 10.1186/1471-2342-8-16.
-
(2008)
BMC Med Imaging
, vol.8
, pp. 16
-
-
Jensen, M.M.1
Jørgensen, J.T.2
Binderup, T.3
Kjaer, A.4
-
20
-
-
1142309545
-
M cell targeting by lectins: A strategy for mucosal vaccination and drug delivery
-
DOI 10.1016/j.addr.2003.10.018
-
Jepson MA, Clark MA, Hirst BH. (2004). M cell targeting by lectins: A strategy for mucosal vaccination and drug delivery. Adv Drug Deliv Rev, 56, 511-525. (Pubitemid 38210420)
-
(2004)
Advanced Drug Delivery Reviews
, vol.56
, Issue.4
, pp. 511-525
-
-
Jepson, M.A.1
Clark, M.A.2
Hirst, B.H.3
-
21
-
-
0021020950
-
Interaction of microspheres with blood constituents: I. Uptake of polystyrene spheres by monocytes and granulocytes and effect on immune responsiveness of lymphocytes
-
Kanke M, Sniecinski I, DeLuca PP. (1983). Interaction of microspheres with blood constituents: I. Uptake of polystyrene spheres by monocytes and granulocytes and effect on immune responsiveness of lymphocytes. J Parenter Sci Technol, 37, 210-217. (Pubitemid 14212779)
-
(1983)
Journal of Parenteral Science and Technology
, vol.37
, Issue.6
, pp. 210-217
-
-
Kanke, M.1
Sniecinski, I.2
Deluca, P.P.3
-
22
-
-
79151473356
-
Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression
-
Krupa M, Canamero M, Gomez CE, Najera JL, Gil J, Esteban M. (2011). Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression. Vaccine, 29, 1504-1513.
-
(2011)
Vaccine
, vol.29
, pp. 1504-1513
-
-
Krupa, M.1
Canamero, M.2
Gomez, C.E.3
Najera, J.L.4
Gil, J.5
Esteban, M.6
-
23
-
-
34147110914
-
Formulation and evaluation of an oral melanoma vaccine
-
DOI 10.1080/02652040601162608, PII 777021462
-
Lai YH, D'Souza MJ. (2007). Formulation and evaluation of an oral melanoma vaccine. J Microencapsul, 24, 235-252. (Pubitemid 46567407)
-
(2007)
Journal of Microencapsulation
, vol.24
, Issue.3
, pp. 235-252
-
-
Lai, Y.H.1
D'Souza, M.2
-
24
-
-
58149380346
-
Delivery systems: A vaccine strategy for overcoming mucosal tolerance?
-
Mann JF, Acevedo R, Campo JD, Párez O, Ferro VA. (2009). Delivery systems: A vaccine strategy for overcoming mucosal tolerance? Expert Rev Vaccines, 8, 103-112.
-
(2009)
Expert Rev Vaccines
, vol.8
, pp. 103-112
-
-
Mann, J.F.1
Acevedo, R.2
Campo, J.D.3
Párez, O.4
Ferro, V.A.5
-
25
-
-
20444453277
-
Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables
-
DOI 10.1158/1078-0432.CCR-04-2337
-
Michael A, Ball G, Quatan N, Wushishi F, Russell N, Whelan J, Chakraborty P, Leader D, Whelan M, Pandha H. (2005). Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables. Clin Cancer Res, 11, 4469-4478. (Pubitemid 40825637)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.12
, pp. 4469-4478
-
-
Michael, A.1
Ball, G.2
Quatan, N.3
Wushishi, F.4
Russell, N.5
Whelan, J.6
Chakraborty, P.7
Leader, D.8
Whelan, M.9
Pandha, H.10
-
26
-
-
0020665445
-
Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells
-
Natali PG, Giacomini P, Bigotti A, Imai K, Nicotra MR, Ng AK, Ferrone S. (1983). Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res, 43, 660-668. (Pubitemid 13193863)
-
(1983)
Cancer Research
, vol.43
, Issue.2
, pp. 660-668
-
-
Natali, P.G.1
Giacomini, P.2
Bigotti, A.3
-
27
-
-
0000507687
-
Microparticles as oral vaccines
-
O'Hagan DT, ed. CRC press
-
O'Hagan DT. (1994). Microparticles as oral vaccines. In: O'Hagan DT, ed. Novel Delivery Systems for Oral Vaccines. CRC press, 175-205.
-
(1994)
Novel Delivery Systems for Oral Vaccines
, pp. 175-205
-
-
O'Hagan, D.T.1
-
28
-
-
0034826521
-
Recent developments in adjuvants for vaccines against infectious diseases
-
O'Hagan DT, MacKichan ML, Singh M. (2001). Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng, 18, 69-85.
-
(2001)
Biomol Eng
, vol.18
, pp. 69-85
-
-
O'Hagan, D.T.1
MacKichan, M.L.2
Singh, M.3
-
29
-
-
0031786697
-
Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms
-
DOI 10.1023/A:1011900527021
-
Savolainen J, Järvinen K, Taipale H, Jarho P, Loftsson T, Järvinen T. (1998). Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm Res, 15, 1696-1701. (Pubitemid 28524579)
-
(1998)
Pharmaceutical Research
, vol.15
, Issue.11
, pp. 1696-1701
-
-
Savolainen, J.1
Jarvinen, K.2
Taipale, H.3
Jarho, P.4
Loftsson, T.5
Jarvinen, T.6
-
30
-
-
80051580618
-
Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths
-
Siegel R, Ward E, Brawley O, Jemal A. (2011). Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-236.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 212-236
-
-
Siegel, R.1
Ward, E.2
Brawley, O.3
Jemal, A.4
-
31
-
-
84859529657
-
Whole cell and lysate vaccines
-
Rosenberg SA, ed. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins
-
Sivanandham M, Stavropoulos C, Wallack M. (2000). Whole cell and lysate vaccines. In: Rosenberg SA, ed. Principles and practice of the biologic therapy of cancer. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 632-644.
-
(2000)
Principles and Practice of the Biologic Therapy of Cancer
, pp. 632-644
-
-
Sivanandham, M.1
Stavropoulos, C.2
Wallack, M.3
-
32
-
-
0034554863
-
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
-
Small EJ, Fratesi P, Reese DM, Strang G, Laus R, Peshwa MV, Valone FH. (2000). Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J Clin Oncol, 18, 3894-3903.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3894-3903
-
-
Small, E.J.1
Fratesi, P.2
Reese, D.M.3
Strang, G.4
Laus, R.5
Peshwa, M.V.6
Valone, F.H.7
-
33
-
-
0024094796
-
Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- And copolymers
-
Tabata Y, Ikada Y. (1988). Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res, 22, 837-858.
-
(1988)
J Biomed Mater Res
, vol.22
, pp. 837-858
-
-
Tabata, Y.1
Ikada, Y.2
-
34
-
-
0037331230
-
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages
-
DOI 10.1023/A:1022271020390
-
Thiele L, Merkle HP, Walter E. (2003). Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res, 20, 221-228. (Pubitemid 36269728)
-
(2003)
Pharmaceutical Research
, vol.20
, Issue.2
, pp. 221-228
-
-
Thiele, L.1
Merkle, H.P.2
Walter, E.3
-
35
-
-
5644226210
-
Orally delivered malaria vaccines: Not too hard to swallow
-
DOI 10.1517/14712598.4.10.1585
-
Wang L, Webster DE, Wesselingh SL, Coppel RL. (2004). Orally delivered malaria vaccines: Not too hard to swallow. Expert Opin Biol Ther, 4, 1585-1594. (Pubitemid 39371754)
-
(2004)
Expert Opinion on Biological Therapy
, vol.4
, Issue.10
, pp. 1585-1594
-
-
Wang, L.1
Webster, D.E.2
Wesselingh, S.L.3
Coppel, R.L.4
-
36
-
-
0035421307
-
Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice
-
Yang D, Holt GE, Velders MP, Kwon ED, Kast WM. (2001). Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res, 61, 5857-5860. (Pubitemid 32769105)
-
(2001)
Cancer Research
, vol.61
, Issue.15
, pp. 5857-5860
-
-
Yang, D.1
Holt, G.E.2
Velders, M.P.3
Kwon, E.D.4
Kast, W.M.5
|